MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT

Temozolomide is a first line anti-tumor drug used for the treatment of patients with Glioblastoma multiforme (GBM). However, the drug resistance to temozolomide limits its clinical application. Therefore, novel strategies to overcome chemoresistance are desperately needed for improved treatment of h...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chengbin, Guo, Ruiming, Guan, Fangxia, Ma, Shanshan, Li, Mu, Wu, Junru, Liu, Xianzhi, Li, Hongwei, Yang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289811/
https://www.ncbi.nlm.nih.gov/pubmed/32528036
http://dx.doi.org/10.1038/s41598-020-65331-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289811/
https://www.ncbi.nlm.nih.gov/pubmed/32528036
http://dx.doi.org/10.1038/s41598-020-65331-3

Ejemplares similares